Back to search

Switzerland· 57583001

Nexavar, Filmtabletten

A sorafenib product containing sorafenibum, registered in Switzerland by Bayer (Schweiz) AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01EX02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNexavar, FilmtablettenATCL01EX02REGISTER NO.57583001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Sorafenib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EX02 (sorafenib), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Sorafenib · ATC L01EX02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sorafenib costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.

  • Switzerland: $125.31 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Sorafenib · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$125.31
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
sorafenibum
Manufacturer
Bayer (Schweiz) AG
Country
Switzerland (CH)
ATC code
L01EX02
ATC class
Sorafenib
Defined daily dose
0.8 g, O
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680575830016
    112 Stk
    CHF 3112.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

598 interactions on record for sorafenib.

Graded by severity as the source publishes them — 85 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sorafenib · interactions on record

598 records

  • 85 severe
  • 352 moderate
  • 11 minor
  • 150 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • EdoxabanB01AF03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sorafenib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sorafenib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Sorafenib, Sorafenib Bluefish
  • Belgium · Sorafenib Eg, Sorafénib Eg
  • Bulgaria · Сорафениб Зентива, Сорафениб Тева
  • Cyprus · Rexanib
  • Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
  • Germany · Sorafeb, Sorafenib Abz
  • Denmark · Sorafenib "sandoz", Sorafenib Stada
  • Estonia · Sorafenib Sandoz, Sorafenib Teva
  • Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
  • Finland · Sorafenib Sandoz, Sorafenib Stada
  • France · Sorafenib Arrow, Sorafenib Biogaran
  • United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
  • Greece · Revamox, Sorafenib Bioars
  • Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
  • Hungary · Fenesa, Renixola
  • Iceland · Nexavar, Sorafenib
  • Italy · Sorafenib Eg, Sorafenib Medac
  • Liechtenstein · Nexavar, Sorafenib Accord
  • Lithuania · Sorafenib Sandoz, Sorafenib Teva
  • Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
  • Latvia · Sorafenib Lv System, Sorafenib Sandoz
  • Malta · Revamox, Sorafenib Pharos
  • Netherlands · Fenesa, Sorafeb
  • Norway · Nexavar, Sorafenib Accord
  • Poland · Sorafenib G.L., Sorafenib Sandoz
  • Portugal · Sorafenib, Sorafenib Eugia
  • Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
  • Sweden · Sorafenib Bluefish, Sorafenib Sandoz
  • Slovenia · Sorafenib Sandoz, Sorafenib Teva
  • Slovakia · Sorafenib, Sorafenib Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3a9ae821-97d3-42ce-bb17-da48856b9e6f
GET /v1/drugs/3a9ae821-97d3-42ce-bb17-da48856b9e6f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "sorafenibum 200 mg",
  "valid_from": "2006-06-01",
  "limitations": "[{\"description\":\"Inoperables Leberzellkarzinom; bei Vorliegen einer Leberzirrhose einzig bei erhaltener Leberfunktion (max. Child Pugh A).<br>\\nProgredientes, lokal fortgeschrittenes oder metastasiertes, Radiojod-refraktäres differenziertes Schilddrüsenkarzinom.<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2018-04-01\"}]",
  "galenic_form": "Filmtabl 200 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2006-06-01",
  "self_retention_pct": 10
}

See everything about sorafenib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.